Please ensure Javascript is enabled for purposes of website accessibility
Don't miss
Home / News / Drug patent settlements may be illegal, DOJ says

Drug patent settlements may be illegal, DOJ says

The U.S. Justice Department said settlements in which makers of brand-name drugs pay to delay the introduction of generic competitors should be considered illegal in many cases. The department, in a filing Monday with the 2nd U.S. Circuit Court of Appeals in New York in a case involving Bayer AG and the anthrax treatment Cipro, said ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*